Drug Database
Back to search

Spain· ES:75770

LAMIVUDINA/ZIDOVUDINA MYLAN 150 mg/300 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A medicinal product containing lamivudina + zidovudina, registered in Spain by Mylan Pharmaceuticals S.L..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedLAMIVUDINA/ZIDOVUDINA MYLAN 150 mg/30…ATC—REGISTER NO.ES:75770PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lamivudina + zidovudinaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

AEMPS CIMA (Spain)
Active substance
lamivudina + zidovudina
Manufacturer
Mylan Pharmaceuticals S.L.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lamivudina + zidovudina in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamivudina + zidovudina products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Belgium · Lamivudine/Zidovudine Viatris
  • Cyprus · Lamivudine/Zidovudine Aurobindo
  • Germany · Lamivudin/Zidovudin, Lamivudin/Zidovudin Accord
  • France · Lamivudine/Zidovudine Arrow, Lamivudine/Zidovudine Viatris
  • United Kingdom (Northern Ireland) · Lamivudine/Zidovudine Milpharm, Lamivudine/Zidovudine Mylan
  • Iceland · Combivir
  • Italy · Lamivudina E Zidovudina Aurobindo, Lamivudina E Zidovudina Mylan
  • Liechtenstein · Combivir
  • Luxembourg · Lamivudine/Zidovudine Viatris
  • Malta · Lamivudine/Zidovudine Mylan
  • Netherlands · Lamivudine/Zidovudine Aurobindo, Lamivudine/Zidovudine Viatris
  • Norway · Combivir
  • Portugal · Lamivudina + Zidovudina Accord, Lamivudina + Zidovudina Aurobindo
  • Romania · Lamivudină/Zidovudină Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7c98182-7b36-4bfb-97b8-db1d355a87c0
GET /v1/drugs/c7c98182-7b36-4bfb-97b8-db1d355a87c0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1334440800000,\"rev\":1707915492000}",
  "nregistro": "75770",
  "substance": "lamivudina + zidovudina"
}
API referenceMCP serverPlans

See everything about lamivudina + zidovudina.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console